7806
精華生醫
1.99%
(0.02)
精華生醫 (7806.TW) 2025Q4 financial report shows revenue of 254.46M TWD, with a YoY growth rate of 13.44%. This figure indicates that 精華生醫 (7806.TW)’s operational performance has remained fundamentally stable. The moderate growth rate reflects a relatively steady market environment. Investors are advised to continuously and closely monitor the company’s future quarterly financial performance and key strategic adjustments. For a more comprehensive and objective assessment of 精華生醫 (7806.TW)’s future growth potential and investment opportunities, it is recommended to incorporate Growin AI Value Analysis for a thorough and prudent evaluation.